文献速递胸部技术与安全PETCT

整合18F-FDG PET/CT播散特征的多参数模型构建与验证用于预测小细胞肺癌结局

Development and validation of multiparametric models incorporating 18F-FDG PET/CT dissemination characteristic for predicting outcomes of small cell lung cancer.
PubMed 文献 · Eur J Radiol · 2025-09-19

回顾性分析303例基线18F-FDG PET/CT的小细胞肺癌患者,随机按7:3分为训练与验证队列,Cox回归筛选独立预后因素并构建列线图。年龄、分期、NSE和SDmax为PFS独立预后因素,年龄、分期、NSE、MTVwb和SDmax为OS独立预后因素,模型AUC在训练与验证队列分别为PFS 0.790/0.778/0.750与0.778/0.771/0.744,OS 0.861/0.830/0.799与0.834/0.801/0.787。

要点

  • SDmax(两病灶间标准化距离)是PFS和OS的独立预后因素。
  • PFS模型纳入年龄、分期、NSE和SDmax,训练队列AUC 0.790/0.778/0.750。
  • OS模型纳入年龄、分期、NSE、MTVwb和SDmax,训练队列AUC 0.861/0.830/0.799。

核心结论

  • 基线18F-FDG PET/CT的肿瘤播散特征是SCLC的新型独立预后因素。
  • 整合播散特征、代谢参数和临床指标的模型在SCLC中显示出良好的预测能力。

研究设计与样本

  • 回顾性分析基线接受18F-FDG PET/CT的SCLC患者,随机按7:3分为训练队列和验证队列。
  • 共纳入303例患者,其中男性204例、女性99例,中位年龄62岁(四分位距56-67岁)。
  • 收集肿瘤播散特征、代谢特征、形态学特征以及临床和病理指标,采用Cox回归分析确定独立预后因素。
  • 构建预后模型及相应列线图,并使用受试者工作特征(ROC)曲线进行评价。

诊断标准与关键数值

  • PFS的多因素Cox回归独立预后因素为年龄、分期、神经元特异性烯醇化酶(NSE)和SDmax。
  • PFS预测6个月、12个月和24个月的AUC在训练队列分别为0.790、0.778和0.750,在验证队列分别为0.778、0.771和0.744。
  • OS的多因素Cox回归独立预后因素为年龄、分期、NSE、全身代谢肿瘤体积(MTVwb)和SDmax。
  • OS预测1年、2年和3年的AUC在训练队列分别为0.861、0.830和0.799,在验证队列分别为0.834、0.801和0.787。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To evaluate the prognostic value of the tumor dissemination characteristic, metabolic parameters from baseline 18F-FDG PET/CT, clinical indicators, and pathological indicators in small cell lung cancer (SCLC), and to construct prognostic models.

MATERIALS & METHODS: SCLC patients who underwent baseline 18F-FDG PET/CT were retrospectively analyzed and randomly divided into training and validation cohorts (7:3). The tumor dissemination characteristic, metabolic characteristics, morphological features, and clinical and pathological indicators were collected. Cox regression analysis was employed to identify independent prognostic factors. Prognostic models and corresponding nomograms were developed and evaluated using receiver operating characteristic (ROC) curves.

RESULTS: 303 patients with SCLC were enrolled (including 204 males and 99 females; median age: 62 years, interquartile range: 56-67 years). Multivariate Cox regression analysis identified age, stage, neuron-specific enolase (NSE), and the standardized distance between the two farthest lesions (SDmax) as independent prognostic factors for progression-free survival (PFS). Area under curve (AUC) values for predicting 6-month, 12-month, and 24-month PFS were 0.790, 0.778, and 0.750 in the training cohort, and 0.778, 0.771, and 0.744 in the validation cohort. For overall survival (OS), age, stage, NSE, whole-body metabolic tumor volume (MTVwb), and SDmax were independent prognostic factors. AUC values for predicting 1-year, 2-year, and 3-year OS were 0.861, 0.830, and 0.799 in the training cohort, and 0.834, 0.801, and 0.787 in the validation cohort.

CONCLUSION: The tumor dissemination characteristic from baseline 18F-FDG PET/CT is a novel independent prognostic factor in SCLC. Additionally, the models incorporating the dissemination characteristic, metabolic parameter, and clinical indicators demonstrate excellent predictive capabilities in SCLC.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Liu Y, Zhou X, Meng X, et al. Development and validation of multiparametric models incorporating 18F-FDG PET/CT dissemination characteristic for predicting outcomes of small cell lung cancer. Eur J Radiol. 2025. PMID: 40992345. doi:10.1016/j.ejrad.2025.112425

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。